Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from IDT Australia Limited ( (AU:IDT) ).
IDT Australia Limited announced the results of its Annual General Meeting, where all resolutions were successfully carried. Key resolutions included the adoption of the remuneration report, the re-election of Dr. Jane Ryan as a director, and the approval of increased placement capacity. These outcomes reflect strong shareholder support and are likely to positively impact the company’s governance and operational capacity.
More about IDT Australia Limited
IDT Australia Limited is a pharmaceutical manufacturing company based in Boronia, Victoria, Australia. The company specializes in the development and production of high potency and high containment pharmaceutical products for both local and international clients. IDT’s facilities are cGMP compliant and regularly audited by the US FDA and Australian TGA. They offer a comprehensive range of services including new drug development, commercial active drug manufacture, and various oral and injectable finished drug dose forms.
Average Trading Volume: 290,947
Technical Sentiment Signal: Sell
Current Market Cap: A$24.69M
See more data about IDT stock on TipRanks’ Stock Analysis page.